ID   EL4
AC   CVCL_0255
SY   EL-4; EL 4; E.L.4
DR   BTO; BTO:0003432
DR   CLO; CLO_0002913
DR   CLO; CLO_0050166
DR   MCCL; MCC:0000146
DR   CLDB; cl1158
DR   CLDB; cl1159
DR   CLDB; cl1160
DR   ATCC; TIB-39
DR   BCRC; 60179
DR   CCRID; 1101MOU-PUMC000136
DR   CCRID; 3101MOUTCM41
DR   CCRID; 4201MOU-CCTCC00136
DR   CCTCC; GDC0136
DR   ChEMBL-Cells; CHEMBL3308380
DR   ChEMBL-Targets; CHEMBL614293
DR   CLS; 300653
DR   DSMZ; ACC-831
DR   DSMZCellDive; ACC-831
DR   ECACC; 85023105
DR   JCRB; IFO50027
DR   JCRB; JCRB1350
DR   KCB; KCB 2013027YJ
DR   KCLB; 40039
DR   Lonza; 760
DR   NCBI_Iran; C114
DR   PRIDE; PXD008733
DR   PubChem_Cell_line; CVCL_0255
DR   RCB; RCB1641
DR   TKG; TKG 0150
DR   Wikidata; Q54832230
RX   PubMed=4099030;
RX   PubMed=4867923;
RX   PubMed=14801344;
RX   PubMed=30084848;
WW   http://www.cells-talk.com/index.php/page/copelibrary?key=EL4
WW   https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-141.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: ~15-20 hours (DSMZ=ACC-831); ~14 hours (Note=Lot 10262015), ~12 hours (Note=Lot 02052018) (JCRB=JCRB1350).
CC   Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: HLA class I peptidome analysis by proteomics.
CC   Discontinued: JCRB; IFO50027; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 29
//
RX   PubMed=4099030; DOI=10.1126/science.171.3966.75;
RA   Mohit B., Fan K.;
RT   "Hybrid cell line from a cloned immunoglobulin-producing mouse myeloma
RT   and a nonproducing mouse lymphoma.";
RL   Science 171:75-77(1971).
//
RX   PubMed=4867923;
RA   Glynn J.P., McCoy J.L., Fefer A.;
RT   "Cross-resistance to the transplantation of syngeneic Friend, Moloney,
RT   and Rauscher virus-induced tumors.";
RL   Cancer Res. 28:434-439(1968).
//
RX   PubMed=14801344; DOI=10.1038/bjc.1950.36;
RA   Gorer P.A.;
RT   "Studies in antibody response of mice to tumour inoculation.";
RL   Br. J. Cancer 4:372-379(1950).
//
RX   PubMed=30084848; DOI=10.1038/sdata.2018.157;
RA   Schuster H., Shao W.-G., Weiss T., Pedrioli P.G.A., Roth P., Weller M.,
RA   Campbell D.S., Deutsch E.W., Moritz R.L., Planz O., Rammensee H.-G.,
RA   Aebersold R., Caron E.;
RT   "A tissue-based draft map of the murine MHC class I immunopeptidome.";
RL   Sci. Data 5:180157-180157(2018).
//